US FDA Extends Roche’s Risdiplam Decision Date

Move Triggered By Roche’s Submission Of Added Trial Data

 
• By Sten Stovall
Spinal_X_Ray
FDA had previously set 24 May as date for deciding whether to approve Roche's drug • Source: Shutterstock

More from Business

More from Scrip